Vivo Capital, LLC
45 holdingsFiling period: 2026-03-31Current AUM: $1.26Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ERAS | Erasca Inc | 12.15M | $196.6M | $220.5M | 17.52% | +2.88M | 2026-03-31 |
| 2 | PRAX | Praxis Precision Medicines | 338.9K | $109.2M | $104.3M | 8.29% | +10.0K | 2026-03-31 |
| 3 | TERN | Terns Pharmaceuticals Inc | 1.33M | $70.3M | $70.3M | 5.59% | -4,012,510 | 2026-03-31 |
| 4 | TRVI | Trevi Therapeutics Inc | 5.09M | $60.8M | $93.0M | 7.39% | -- | 2026-03-31 |
| 5 | DBVT | DBV Technologies SA | 2.67M | $55.7M | $36.0M | 2.86% | +205.9K | 2026-03-31 |
| 6 | CMPX | Compass Therapeutics Inc | 9.55M | $50.5M | $18.2M | 1.45% | -- | 2026-03-31 |
| 7 | TNGX | Tango Therapeutics Inc | 2.15M | $45.1M | $58.6M | 4.65% | -- | 2026-03-31 |
| 8 | SABS | SAB Biotherapeutics Inc | 11.42M | $43.7M | $40.8M | 3.24% | -- | 2026-03-31 |
| 9 | CRVS | Corvus Pharmaceuticals Holdings | 2.81M | $41.0M | $37.2M | 2.96% | +571.3K | 2026-03-31 |
| 10 | DRUG | Bright Minds Biosciences Inc | 557.2K | $40.7M | $40.8M | 3.24% | +55.6K | 2026-03-31 |
| 11 | — | Sinovac Biotech Ltd. | 5.90M | $38.2M | $38.2M | 3.03% | -- | 2026-03-31 |
| 12 | DNTH | Dianthus Therapeutics Inc | 354.0K | $29.7M | $37.8M | 3.01% | -- | 2026-03-31 |
| 13 | DYN | Dyne Therapeutics Inc | 1.56M | $28.2M | $39.2M | 3.12% | -1,057,494 | 2026-03-31 |
| 14 | ABVX | Abivax SA - ADR | 239.5K | $26.7M | $29.9M | 2.38% | -119,766 | 2026-03-31 |
| 15 | NERV | Minerva Neurosciences Inc | 4.32M | $26.0M | $17.2M | 1.37% | -- | 2026-03-31 |
| 16 | ACRS | Aclaris Therapeutics, Inc. | 6.67M | $25.0M | $34.7M | 2.75% | -2,222,222 | 2026-03-31 |
| 17 | ORIC | Oric Pharmaceuticals Inc | 1.85M | $23.4M | $20.5M | 1.63% | -269,598 | 2026-03-31 |
| 18 | ANRO | Alto Neuroscience Inc | 1.04M | $23.3M | $28.0M | 2.23% | -- | 2026-03-31 |
| 19 | SNSE | Sensei Biotherapeutics Inc | 722.0K | $22.8M | $22.8M | 1.81% | -- | 2026-03-31 |
| 20 | AVBP | Arrivent BioPharma Inc | 885.9K | $20.4M | $26.4M | 2.10% | -- | 2026-03-31 |
| 21 | LBRX | LB Pharmaceuticals Inc | 800.0K | $19.7M | $32.1M | 2.55% | -- | 2026-03-31 |
| 22 | MANE | Veradermics Inc | 300.0K | $18.9M | $31.5M | 2.50% | -- | 2026-03-31 |
| 23 | CAMP | CAMP4 Therapeutics Inc | 4.25M | $18.7M | $14.7M | 1.16% | -- | 2026-03-31 |
| 24 | MLTX | Moonlake Immunotherapeutics | 1.00M | $18.6M | $18.4M | 1.46% | -- | 2026-03-31 |
| 25 | DSGN | Design Therapeutics Inc | 1.61M | $17.2M | $19.6M | 1.56% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2